NCT02389439View on ClinicalTrials.gov

Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

December 1, 2015

Study Completion Date

June 1, 2016

Conditions
Malaria, Falciparum
Interventions
DRUG

Pyronaridine-artesunate

Trial Locations (3)

Unknown

Tasanh Health Centre, Battambang, Battambang

Referral hospital (Pailin), Pailin

Promoy Health Centre (Pursat), Pursat

All Listed Sponsors
collaborator

NCHADS - Ministry of Health of Cambodia

OTHER

lead

University of Oxford

OTHER

NCT02389439 - Efficacy and Safety of Pyronaridine-artesunate for the Treatment in Uncomplicated Falciparum Malaria | Biotech Hunter | Biotech Hunter